Ziyao Wang Du He Chen Chen Xubao Liu Nengwen Ke
10.3389/fonc.2021.801320
Front Oncol
2022 Jan 25;11:801320.
braf v600e pdac benefit survival trametinib vemurafenib
CC BY
https://pubmed.ncbi.nlm.nih.gov/35145907/
Case Reports
PMC8821913
35145907
Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report
2022